A retrospective analysis to demonstrate achievable dosimetry for the left anterior descending artery in left-sided breast cancer patients treated with radiotherapy.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
07 2020
Historique:
received: 18 12 2019
revised: 14 04 2020
accepted: 15 04 2020
pubmed: 11 5 2020
medline: 15 4 2021
entrez: 11 5 2020
Statut: ppublish

Résumé

To demonstrate achievable dose for the left anterior descending artery (LAD) for left-sided breast cancer patients. A retrospective analysis was conducted on all left-sided breast cancer patients receiving whole breast or post-mastectomy chest wall irradiation between 2013 and 2018. All patients in this study were treated with tangent-based techniques with the LAD prospectively contoured as routine clinical care. This large patient cohort was used to benchmark achievable mean doses to the LAD in the context of heart dose. The primary cohort of study were patients undergoing treatment with deep-inspiration breath-hold (DIBH), stratified by internal mammary nodes (IMN) inclusion. In all cases, the median (25th-75th percentile) is reported. A total of 1221 left-sided breast cancer patients were included in this study with 1045 in the DIBH cohort. The median heart mean dose for this cohort is 1.0 Gy (0.8-1.1). For patients treated in DIBH with IMNs included (n = 422), the median of the mean LAD dose is 3.6 Gy (2.9-4.4) and, for patients treated in DIBH with IMNs excluded (n = 623), the median of the mean LAD dose is 3.2 Gy (2.5-3.8). Appropriate respiratory management can be utilized to achieve low dose to the LAD for the majority of patients without compromising target coverage.

Identifiants

pubmed: 32388151
pii: S0167-8140(20)30203-6
doi: 10.1016/j.radonc.2020.04.022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-173

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Sarah Quirk (S)

Department of Oncology, University of Calgary, Canada; Department of Physics & Astronomy, University of Calgary, Canada. Electronic address: sarah.quirk@albertahealthservices.ca.

Petra Grendarova (P)

Department of Oncology, University of Calgary, Canada.

Tien Phan (T)

Department of Oncology, University of Calgary, Canada.

Leigh Conroy (L)

Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.

Ben Burke (B)

Department of Oncology, University of Alberta, Edmonton, Canada.

Karen Long (K)

Tom Baker Cancer Centre, Calgary, Canada.

Kundan Thind (K)

Department of Oncology, University of Calgary, Canada; Department of Physics & Astronomy, University of Calgary, Canada.

Jeffrey Cao (J)

Department of Oncology, University of Calgary, Canada.

Peter Craighead (P)

Department of Oncology, University of Calgary, Canada.

Ivo A Olivotto (IA)

Department of Oncology, University of Calgary, Canada.

Michael Roumeliotis (M)

Department of Oncology, University of Calgary, Canada; Department of Physics & Astronomy, University of Calgary, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH